-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical News, April 26, Johnson & Johnson (Johnson & Johnson).
In the first quarter of 2021, sales were US$22.
321 billion, a year-on-year increase of 7.
9%; net profit was US$6.
197 billion, a year-on-year increase of 6.
9%.
By business, sales of the pharmaceutical business were US$12.
199 billion, a year-on-year increase of 9.
6%, of which the sales of new crown vaccines were US$100 million.
The sales of medical device business was US$6.
579 billion, a year-on-year increase of 10.
9%.
Consumer health business sales were US$3.
543 billion, a year-on-year decrease of 2.
3%.
In the first quarter of 2021, sales were US$22.
321 billion, a year-on-year increase of 7.
9%; net profit was US$6.
197 billion, a year-on-year increase of 6.
9%.
By business, sales of the pharmaceutical business were US$12.
199 billion, a year-on-year increase of 9.
6%, of which the sales of new crown vaccines were US$100 million.
The sales of medical device business was US$6.
579 billion, a year-on-year increase of 10.
9%.
Consumer health business sales were US$3.
543 billion, a year-on-year decrease of 2.
3%.
Abbott.
In the first quarter of 2021, net sales were 10.
456 billion U.
S.
dollars, a year-on-year increase of 35.
3%; net profit was 1.
793 billion U.
S.
dollars, a year-on-year increase of 217.
8%.
By business, the nutrition business sales were US$2.
036 billion, a year-on-year increase of 6.
9%; the diagnostic business sales were US$4.
014 billion, a year-on-year increase of 119.
8%; the pharmaceutical business sales were US$1.
070 billion, a year-on-year increase of 2.
5%; and the medical device business sales The amount was US$3.
320 billion, a year-on-year increase of 13.
1%.
In the first quarter of 2021, net sales were 10.
456 billion U.
S.
dollars, a year-on-year increase of 35.
3%; net profit was 1.
793 billion U.
S.
dollars, a year-on-year increase of 217.
8%.
By business, the nutrition business sales were US$2.
036 billion, a year-on-year increase of 6.
9%; the diagnostic business sales were US$4.
014 billion, a year-on-year increase of 119.
8%; the pharmaceutical business sales were US$1.
070 billion, a year-on-year increase of 2.
5%; and the medical device business sales The amount was US$3.
320 billion, a year-on-year increase of 13.
1%.
General Electric (GE) announced the 2020 fourth quarter and full year results.
The total revenue for the fourth quarter was 21.
928 billion US dollars, compared with 26.
238 billion US dollars in the same period last year.
Among them, industrial revenue was 20.
271 billion U.
S.
dollars, compared with 24.
46 billion U.
S.
dollars in the same period last year.
The quarterly net profit was US$2.
442 billion, compared with US$538 million in the same period last year.
By business, power generation business revenue was US$5.
383 billion, renewable energy business revenue was US$4.
442 billion, aviation business revenue was US$5.
847 billion, and medical business revenue was US$4.
823 billion, a year-on-year decrease of 11%.
The total revenue in 2020 was 79.
619 billion US dollars, compared with 95.
214 billion US dollars last year.
The net profit for the year was US$5.
23 billion, and the net loss of the previous year was US$5.
439 billion.
The total revenue for the fourth quarter was 21.
928 billion US dollars, compared with 26.
238 billion US dollars in the same period last year.
Among them, industrial revenue was 20.
271 billion U.
S.
dollars, compared with 24.
46 billion U.
S.
dollars in the same period last year.
The quarterly net profit was US$2.
442 billion, compared with US$538 million in the same period last year.
By business, power generation business revenue was US$5.
383 billion, renewable energy business revenue was US$4.
442 billion, aviation business revenue was US$5.
847 billion, and medical business revenue was US$4.
823 billion, a year-on-year decrease of 11%.
The total revenue in 2020 was 79.
619 billion US dollars, compared with 95.
214 billion US dollars last year.
The net profit for the year was US$5.
23 billion, and the net loss of the previous year was US$5.
439 billion.
Siemens (Siemens) announced the first quarter of fiscal 2021 (as of December 31, 2020) results.
Quarterly revenue was 14.
071 billion euros (approximately 17 billion US dollars), compared with 13.
675 billion euros in the same period last year.
The quarterly net profit was 1.
498 billion euros, compared with 1.
089 billion euros in the same period last year.
Among them, the digital industry group's revenue is 3.
765 billion euros, the intelligent infrastructure group's revenue is 3.
477 billion euros, and the transportation business revenue is 2.
193 billion euros.
Siemens Medical's revenue was 3.
868 billion euros.
Quarterly revenue was 14.
071 billion euros (approximately 17 billion US dollars), compared with 13.
675 billion euros in the same period last year.
The quarterly net profit was 1.
498 billion euros, compared with 1.
089 billion euros in the same period last year.
Among them, the digital industry group's revenue is 3.
765 billion euros, the intelligent infrastructure group's revenue is 3.
477 billion euros, and the transportation business revenue is 2.
193 billion euros.
Siemens Medical's revenue was 3.
868 billion euros.
Aier Ophthalmology.
In the first quarter of 2021, the company achieved operating income of 3.
511 billion yuan, a year-on-year increase of 113.
90%; net profit attributable to shareholders of listed companies was 484 million yuan, a year-on-year increase of 509.
88%.
In the first quarter of 2021, the company achieved operating income of 3.
511 billion yuan, a year-on-year increase of 113.
90%; net profit attributable to shareholders of listed companies was 484 million yuan, a year-on-year increase of 509.
88%.
Medical News, April 26, Johnson & Johnson (Johnson & Johnson).
In the first quarter of 2021, sales were US$22.
321 billion, a year-on-year increase of 7.
9%; net profit was US$6.
197 billion, a year-on-year increase of 6.
9%.
By business, sales of the pharmaceutical business were US$12.
199 billion, a year-on-year increase of 9.
6%, of which the sales of new crown vaccines were US$100 million.
The sales of medical device business was US$6.
579 billion, a year-on-year increase of 10.
9%.
Consumer health business sales were US$3.
543 billion, a year-on-year decrease of 2.
3%.
In the first quarter of 2021, sales were US$22.
321 billion, a year-on-year increase of 7.
9%; net profit was US$6.
197 billion, a year-on-year increase of 6.
9%.
By business, sales of the pharmaceutical business were US$12.
199 billion, a year-on-year increase of 9.
6%, of which the sales of new crown vaccines were US$100 million.
The sales of medical device business was US$6.
579 billion, a year-on-year increase of 10.
9%.
Consumer health business sales were US$3.
543 billion, a year-on-year decrease of 2.
3%.
Abbott.
In the first quarter of 2021, net sales were 10.
456 billion U.
S.
dollars, a year-on-year increase of 35.
3%; net profit was 1.
793 billion U.
S.
dollars, a year-on-year increase of 217.
8%.
By business, the nutrition business sales were US$2.
036 billion, a year-on-year increase of 6.
9%; the diagnostic business sales were US$4.
014 billion, a year-on-year increase of 119.
8%; the pharmaceutical business sales were US$1.
070 billion, a year-on-year increase of 2.
5%; and the medical device business sales The amount was US$3.
320 billion, a year-on-year increase of 13.
1%.
In the first quarter of 2021, net sales were 10.
456 billion U.
S.
dollars, a year-on-year increase of 35.
3%; net profit was 1.
793 billion U.
S.
dollars, a year-on-year increase of 217.
8%.
By business, the nutrition business sales were US$2.
036 billion, a year-on-year increase of 6.
9%; the diagnostic business sales were US$4.
014 billion, a year-on-year increase of 119.
8%; the pharmaceutical business sales were US$1.
070 billion, a year-on-year increase of 2.
5%; and the medical device business sales The amount was US$3.
320 billion, a year-on-year increase of 13.
1%.
General Electric (GE) announced the 2020 fourth quarter and full year results.
The total revenue for the fourth quarter was 21.
928 billion US dollars, compared with 26.
238 billion US dollars in the same period last year.
Among them, industrial revenue was 20.
271 billion U.
S.
dollars, compared with 24.
46 billion U.
S.
dollars in the same period last year.
The quarterly net profit was US$2.
442 billion, compared with US$538 million in the same period last year.
By business, power generation business revenue was US$5.
383 billion, renewable energy business revenue was US$4.
442 billion, aviation business revenue was US$5.
847 billion, and medical business revenue was US$4.
823 billion, a year-on-year decrease of 11%.
The total revenue in 2020 was 79.
619 billion US dollars, compared with 95.
214 billion US dollars last year.
The net profit for the year was US$5.
23 billion, and the net loss of the previous year was US$5.
439 billion.
The total revenue for the fourth quarter was 21.
928 billion US dollars, compared with 26.
238 billion US dollars in the same period last year.
Among them, industrial revenue was 20.
271 billion U.
S.
dollars, compared with 24.
46 billion U.
S.
dollars in the same period last year.
The quarterly net profit was US$2.
442 billion, compared with US$538 million in the same period last year.
By business, power generation business revenue was US$5.
383 billion, renewable energy business revenue was US$4.
442 billion, aviation business revenue was US$5.
847 billion, and medical business revenue was US$4.
823 billion, a year-on-year decrease of 11%.
The total revenue in 2020 was 79.
619 billion US dollars, compared with 95.
214 billion US dollars last year.
The net profit for the year was US$5.
23 billion, and the net loss of the previous year was US$5.
439 billion.
Siemens (Siemens) announced the first quarter of fiscal 2021 (as of December 31, 2020) results.
Quarterly revenue was 14.
071 billion euros (approximately 17 billion US dollars), compared with 13.
675 billion euros in the same period last year.
The quarterly net profit was 1.
498 billion euros, compared with 1.
089 billion euros in the same period last year.
Among them, the digital industry group's revenue is 3.
765 billion euros, the intelligent infrastructure group's revenue is 3.
477 billion euros, and the transportation business revenue is 2.
193 billion euros.
Siemens Medical's revenue was 3.
868 billion euros.
Quarterly revenue was 14.
071 billion euros (approximately 17 billion US dollars), compared with 13.
675 billion euros in the same period last year.
The quarterly net profit was 1.
498 billion euros, compared with 1.
089 billion euros in the same period last year.
Among them, the digital industry group's revenue is 3.
765 billion euros, the intelligent infrastructure group's revenue is 3.
477 billion euros, and the transportation business revenue is 2.
193 billion euros.
Siemens Medical's revenue was 3.
868 billion euros.
Aier Ophthalmology.
In the first quarter of 2021, the company achieved operating income of 3.
511 billion yuan, a year-on-year increase of 113.
90%; net profit attributable to shareholders of listed companies was 484 million yuan, a year-on-year increase of 509.
88%.
In the first quarter of 2021, the company achieved operating income of 3.
511 billion yuan, a year-on-year increase of 113.
90%; net profit attributable to shareholders of listed companies was 484 million yuan, a year-on-year increase of 509.
88%.
Medical News, April 26, Johnson & Johnson (Johnson & Johnson).
In the first quarter of 2021, sales were US$22.
321 billion, a year-on-year increase of 7.
9%; net profit was US$6.
197 billion, a year-on-year increase of 6.
9%.
By business, sales of the pharmaceutical business were US$12.
199 billion, a year-on-year increase of 9.
6%, of which the sales of new crown vaccines were US$100 million.
The sales of medical device business was US$6.
579 billion, a year-on-year increase of 10.
9%.
Consumer health business sales were US$3.
543 billion, a year-on-year decrease of 2.
3%.
In the first quarter of 2021, sales were US$22.
321 billion, a year-on-year increase of 7.
9%; net profit was US$6.
197 billion, a year-on-year increase of 6.
9%.
By business, sales of the pharmaceutical business were US$12.
199 billion, a year-on-year increase of 9.
6%, of which the sales of new crown vaccines were US$100 million.
The sales of medical device business was US$6.
579 billion, a year-on-year increase of 10.
9%.
Consumer health business sales were US$3.
543 billion, a year-on-year decrease of 2.
3%.
Abbott.
In the first quarter of 2021, net sales were 10.
456 billion U.
S.
dollars, a year-on-year increase of 35.
3%; net profit was 1.
793 billion U.
S.
dollars, a year-on-year increase of 217.
8%.
By business, the nutrition business sales were US$2.
036 billion, a year-on-year increase of 6.
9%; the diagnostic business sales were US$4.
014 billion, a year-on-year increase of 119.
8%; the pharmaceutical business sales were US$1.
070 billion, a year-on-year increase of 2.
5%; and the medical device business sales The amount was US$3.
320 billion, a year-on-year increase of 13.
1%.
Medical equipment medical equipment medical equipmentIn the first quarter of 2021, net sales were 10.
456 billion U.
S.
dollars, a year-on-year increase of 35.
3%; net profit was 1.
793 billion U.
S.
dollars, a year-on-year increase of 217.
8%.
By business, the nutrition business sales were US$2.
036 billion, a year-on-year increase of 6.
9%; the diagnostic business sales were US$4.
014 billion, a year-on-year increase of 119.
8%; the pharmaceutical business sales were US$1.
070 billion, a year-on-year increase of 2.
5%; and the medical device business sales The amount was US$3.
320 billion, a year-on-year increase of 13.
1%.
General Electric (GE) announced the 2020 fourth quarter and full year results.
The total revenue for the fourth quarter was 21.
928 billion US dollars, compared with 26.
238 billion US dollars in the same period last year.
Among them, industrial revenue was 20.
271 billion U.
S.
dollars, compared with 24.
46 billion U.
S.
dollars in the same period last year.
The quarterly net profit was US$2.
442 billion, compared with US$538 million in the same period last year.
By business, power generation business revenue was US$5.
383 billion, renewable energy business revenue was US$4.
442 billion, aviation business revenue was US$5.
847 billion, and medical business revenue was US$4.
823 billion, a year-on-year decrease of 11%.
The total revenue in 2020 was 79.
619 billion US dollars, compared with 95.
214 billion US dollars last year.
The net profit for the year was US$5.
23 billion, and the net loss of the previous year was US$5.
439 billion.
The total revenue for the fourth quarter was 21.
928 billion US dollars, compared with 26.
238 billion US dollars in the same period last year.
Among them, industrial revenue was 20.
271 billion U.
S.
dollars, compared with 24.
46 billion U.
S.
dollars in the same period last year.
The quarterly net profit was US$2.
442 billion, compared with US$538 million in the same period last year.
By business, power generation business revenue was US$5.
383 billion, renewable energy business revenue was US$4.
442 billion, aviation business revenue was US$5.
847 billion, and medical business revenue was US$4.
823 billion, a year-on-year decrease of 11%.
The total revenue in 2020 was 79.
619 billion US dollars, compared with 95.
214 billion US dollars last year.
The net profit for the year was US$5.
23 billion, and the net loss of the previous year was US$5.
439 billion.
Siemens (Siemens) announced the first quarter of fiscal 2021 (as of December 31, 2020) results.
Quarterly revenue was 14.
071 billion euros (approximately 17 billion US dollars), compared with 13.
675 billion euros in the same period last year.
The quarterly net profit was 1.
498 billion euros, compared with 1.
089 billion euros in the same period last year.
Among them, the digital industry group's revenue is 3.
765 billion euros, the intelligent infrastructure group's revenue is 3.
477 billion euros, and the transportation business revenue is 2.
193 billion euros.
Siemens Medical's revenue was 3.
868 billion euros.
Quarterly revenue was 14.
071 billion euros (approximately 17 billion US dollars), compared with 13.
675 billion euros in the same period last year.
The quarterly net profit was 1.
498 billion euros, compared with 1.
089 billion euros in the same period last year.
Among them, the digital industry group's revenue is 3.
765 billion euros, the intelligent infrastructure group's revenue is 3.
477 billion euros, and the transportation business revenue is 2.
193 billion euros.
Siemens Medical's revenue was 3.
868 billion euros.
Aier Ophthalmology.
In the first quarter of 2021, the company achieved operating income of 3.
511 billion yuan, a year-on-year increase of 113.
90%; net profit attributable to shareholders of listed companies was 484 million yuan, a year-on-year increase of 509.
88%.
In the first quarter of 2021, the company achieved operating income of 3.
511 billion yuan, a year-on-year increase of 113.
90%; net profit attributable to shareholders of listed companies was 484 million yuan, a year-on-year increase of 509.
88%.
